MACMIROR COMPLEX 12 OV VAG

MACMIROR COMPLEX 500 MG/2000.000 UI OVULI

active ingredients

Each egg contains: nifuratel mg 500; nistatina U.I. 200.000. For the full list of excipients, see paragraph 6.1.

Excellent

Dimethylpolysisthexane AK 1000. Components the capsule: gelatin; glycerin; sodium etil-4-hydroxybenzoate; sodium propil-4-hydroxybenzoate; titanium dioxide; iron oxide yellow.

Therapeutic indications

Polyvalent therapy of vulvovaginal diseases from pathogenic microorganisms: Candida, Trichomonas and bacteria.

Contraindications

Hypersensitivity to active ingredients or any of the excipients listed in paragraph 6.1.

Population

1 ovum per day. To achieve the most favorable therapeutic effect, it is necessary that the eggs be brought to the highest part of the vagina.

Conservation

Nothing to report.

Warnings

The use, prolonged species of the product, can give rise to phenomena of sensitization. In the case of the appearance of reaction of hypersensitivity the administration of the drug must be interrupted. During treatment refrain from sexual intercourse.

Interactions

Pharmacological interactions with MACMIROR COMPLEX components have not been described.

Effects

No side effects have been reported. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

Not to be considered, given the way of administration.

There are no contraindications.

Source: Farmadati